|
- 2019
First Case of Cytokine Release Syndrome after Nivolumab for Gastric CancerDOI: 10.1159/000496933 Keywords: Cytokine release syndrome, Gastric cancer, Nivolumab, Liver injury, TNF-α Abstract: Cytokine release syndrome (CRS) is a potentially life-threatening systemic disease that has been observed after treatment with antibodies and adoptive T cell therapies. In this case, we observed nivolumab-induced CRS in a patient with gastric cancer
|